More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

Cynata Files Application to Commence Phase 1 Clinical Trial

Jul 31, 2016 at 11:06 PM EDT · Issued by Cynata Therapeutics Limited

Filed with ASX · Jul 31, 2016 at 11:06 PM EDT · 1 page · English

On 6ix: 6ix.com/news/cynata-files-application-to-commence-phase-1-clinical-trial

Cynata Therapeutics Limited on 6ix

Story so far

  • Cynata Prepares for Phase 1 Clinical TrialJun 21, 2016
  • CYP Manufactures CT Product-Files Further Patent ApplicationMay 5, 2016

Earlier from Cynata Therapeutics

  • Cynata Receives Investment Offer from RegienceJun 30, 2016
  • Cynata Prepares for Phase 1 Clinical TrialJun 20, 2016
  • Cynata Enters Agreement with apceth GmbH & Co KGMay 8, 2016
  • CYP Manufactures CT Product-Files Further Patent ApplicationMay 5, 2016
  • Decision to Grant Patent for Cymerus MSC Technology in JapanMay 2, 2016

Later from Cynata Therapeutics

  • CYP & FUJIFILM Sign Non-Binding Terms SheetSep 4, 2016
  • CYP Determines not to proceed with Regience Investment OfferSep 5, 2016
  • UK Regulatory Authority Approves Cynata GvHD Clinical TrialSep 19, 2016
  • Efficacy for CYP MSC Technology in Preclinical Asthma StudyOct 16, 2016
  • Activities Report & Appendix 4COct 31, 2016
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer